Skip to main content
. 2024 Jan 19;103(3):e37016. doi: 10.1097/MD.0000000000037016

Table 2.

The summary of prognostic data meta-analysis.

Target molecule Survival type Number of Studies Hazard ratio Confidence interval P value of HR I 2 P value of I2
Cyclin B1 OS 7 1.69 1.35–2.12 <.01 23% .25
DSS 2 1.71 1.37–2.13 <.01 0% .82
DFS 7 2.01 1.18–3.42 .01 73% <.01
Cyclin B2 DSS 4 2.46 1.19–5.07 .02 91% <.01

DFS = disease free survival, DSS = disease specific survival, OS = overall survival.